We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Vaginal Fluid Transplantation Could Treat Intractable Vaginosis

By HospiMedica International staff writers
Posted on 26 Oct 2019
Print article
Vaginal microbiome transplantation (VMT) from a healthy donor to women with recurrent bacterial vaginosis could restore the microbiome, claims a new study.

Researchers at the Hebrew University (HUJI; Jerusalem, Israel), Hadassah Medical Center (Jerusalem, Israel), the Weizmann Institute of Science (Rehovot, Israel), and other institutions conducted a case series study of five women (27-47 years of age) suffering from symptomatic, intractable, and recurrent bacterial vaginosis. The women were all on continuous antibiotics. Prior to VMT, the women were asked to stop antibiotics they were on, and were provided with a vaginal antibiotic cream to be applied regularly. Healthy vaginal fluids from three healthy women donors were then collected and transferred.

Donor women were asked to abstain from sexual intercourse for at least a week before the donation, and the recipient women were put on birth control, to prevent unwanted contraception. The results of VMT revealed that four of the women underwent full long-term remission; three of them necessitated repeat VMT, including a donor change in one patient, to elicit a long-standing clinical response. One patient presented with incomplete remission in clinical and laboratory features, and no adverse effects were observed in any of the five women. The study was published on October 7, 2019, in Nature.

“With this friendly microbiome takeover, symptoms and complications associated with bacterial vaginosis rapidly subside,” said senior author Professor Eran Elinav, PhD, of the Weizmann Institute of Science department of immunology. “By introducing this new treatment approach, we hope that we may come a step closer to providing an affordable solution for the very many millions of women across the world that suffer with this disorder.”

Bacterial vaginosis is a common condition that affects one in three women of the reproductive age and usually occurs when the balance between healthy and harmful bacteria is tipped towards the latter, with a sharp fall in the number of healthy lactobacilli. It is commonly associated with a discharge that smells foul and fishy. While not life threatening, it may increase vulnerability to sexually transmitted infections (STIs), lead to infertility, and may cause complications in pregnant woman. In most cases, antibiotics are prescribed, but the rate of recurrence is high.

Related Links:
Hebrew University
Hadassah Medical Center
Weizmann Institute of Science
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Soft-Tissues Biopsy Needle
MR-CLEAR

Print article

Channels

Critical Care

view channel
Image: The potential for controlling diabetes with a single endoscopic treatment is spectacular (Photo courtesy of 123RF)

One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes

Over 37 million Americans are diagnosed with diabetes, and more than 90% of these cases are Type 2 diabetes. This form of diabetes is most commonly seen in individuals over 45, though an increasing number... Read more

Surgical Techniques

view channel
Image: The FieldForce Catheter is the first and only contact force PFA catheter optimized for the ventricles (Photo courtesy of Field Medical)

First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias

It is estimated that over 6 million patients in the US and Europe are affected by ventricular arrhythmias, which include conditions such as ventricular tachycardia (VT) and premature ventricular contractions (PVCs).... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more